Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 991 | 991 | 908 | 926 | 882 | - |
Fund Return | -0.92% | -0.92% | -9.18% | -2.52% | -2.48% | - |
Place in category | 67 | 67 | 64 | 65 | 67 | - |
% in Category | 44 | 44 | 49 | 60 | 80 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Bualuang Long Term Equity Fund | 33.92B | 0.77 | -5.89 | -0.97 | ||
Bualuang Fixed Income | 21.56B | 2.41 | 1.37 | 1.52 | ||
Bualuang Long Term Equity Fund 75 | 18.69B | -0.09 | -4.90 | -0.66 | ||
Bualuang Flexible RMF | 18.75B | 0.03 | -5.37 | -1.00 | ||
Bualuang FixedIncome RMF | 11.45B | 2.71 | 1.41 | 1.45 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Phatra Long Term Equity Dividend Fu | 4.51B | 0.06 | -5.14 | 0.23 | ||
K Mid Small Cap Equity RMF | 3.88B | -1.02 | -0.81 | - | ||
Bualuang Siriphol Corporate GovRMF | 3.08B | 0.61 | -0.91 | 0.06 | ||
Bualuang Siriphol Corporate Govern | 2.6B | 0.60 | -0.89 | 0.11 | ||
Bualuang Basic RMF | 2.51B | -3.03 | -3.86 | -0.99 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Bangkok Dusit Medical | TH0264A10Z04 | 5.86 | 26.25 | -0.94% | |
CP All PCL | TH0737010Y08 | 5.59 | 64.00 | +1.19% | |
Central Pattana | TH0481B10Z00 | 4.25 | 62.25 | +0.81% | |
Siam Cement | TH0003010Z04 | 4.07 | 195.50 | +1.82% | |
MC Group | TH4625010004 | 3.42 | 10.90 | -0.91% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review